You are viewing the site in preview mode

Skip to main content
Fig. 5 | Clinical Proteomics

Fig. 5

From: Comprehensive analysis of chronic hepatitis B concurrent with non-alcoholic fatty liver disease: a proteomics report based on clinical liver samples

Fig. 5

(A) Establishment of mouse models of HBV, NAFLD and NAFLD combined with HBV infection. (B) HE staining of liver tissues (C) Changes in body weight of mice over time (D) Serum TG and TC secretion levels in four groups of mice (E) Serum levels of HBsAg, HBeAg and HBV-DNA of mice (F) Validation of differential gene expression by qRT-PCR

Back to article page